Adaptogens aren't working. Your genes may be why.

Your COMT gene encodes an enzyme that breaks down dopamine, norepinephrine, and epinephrine, the three stress hormones that make your heart race and your mind spin. When COMT is working normally, it clears these hormones quickly after a stressor passes, allowing you to return to baseline within minutes to hours.

If you carry the slow COMT variant (Val158Met), your enzyme works 40-70% less efficiently than people with the fast version. This means stress hormones like epinephrine and norepinephrine circulate in your bloodstream longer, keeping your nervous system in a heightened state even after the threat has passed. Roughly 25% of people with European ancestry are homozygous for the slow variant, meaning they inherited the slower version from both parents.

You feel this as persistent wired-ness, difficulty unwinding after work, racing thoughts at night, or a constant low-grade sense of urgency. You might be emotionally reactive, easily startled, or unable to sit still. Caffeine, stimulating adaptogens, or high-intensity exercise make you feel worse because they further elevate the stress hormones your body is already struggling to clear.

Your FKBP5 gene encodes a protein that helps your body sense cortisol and turn off the stress response when the danger has passed. When FKBP5 is working normally, cortisol binds to its receptor, triggers negative feedback, and the HPA axis downregulates. The stress response shuts off cleanly.

If you carry the rs1360780 variant, your FKBP5 protein becomes less sensitive to cortisol signals. This means your body struggles to recognize that stress is over, and cortisol remains elevated even hours or days after a stressor has passed. Roughly 30% of the population carries at least one copy of this variant, but its impact is strongest in people who experienced childhood stress or ongoing environmental pressures.

You experience this as difficulty recovering from work stress, feeling on edge even during relaxation, or waking up with morning cortisol that doesn’t drop. Your nervous system stays in sympathetic dominance, making rest feel impossible. You might feel exhausted but wired at the same time. Adaptogens that support HPA axis tone can help, but only if you also address the underlying feedback impairment.

Your SLC6A4 gene encodes the serotonin transporter, a protein that recycles serotonin back into nerve cells after it’s been released. When serotonin lingers in the synapse longer, you feel calmer, more social, more resilient to stress. Your SLC6A4 is the gatekeeper of how long serotonin stays available.

If you carry the short allele of the 5-HTTLPR variant, your serotonin transporter recycles serotonin more aggressively, meaning less serotonin stays in the synapse where it can work. This creates chronically lower serotonin availability, especially under stress, leaving you more anxious, more irritable, and less able to bounce back emotionally. Roughly 40% of the population carries at least one short allele, and this variant has been associated with heightened reactivity to social stress and threat.

You feel this as social anxiety, difficulty handling criticism, mood crashes after stressful events, or an inability to feel reassured once worry starts. Adaptogens alone won’t fix low serotonin availability. You need interventions that increase serotonin synthesis or reduce its breakdown, not general stress modulators.

Your MAOA gene encodes monoamine oxidase A, an enzyme that breaks down serotonin, dopamine, and norepinephrine. MAOA controls how quickly these neurotransmitters are metabolized. When MAOA is highly active, neurotransmitters are cleared quickly. When it’s less active, they linger, creating higher steady-state levels.

If you carry the MAOA-L variant (low-activity), your enzyme degrades neurotransmitters more slowly. This means dopamine, serotonin, and norepinephrine can accumulate to higher levels, creating emotional intensity, heightened sensory reactivity, and a more sensitive stress response overall. Roughly 30-40% of males carry the low-activity variant (females have two X chromosomes, making the genetics more complex). People with MAOA-L tend to be more emotionally reactive, more sensitive to stimuli, and more prone to intense mood swings under stress.

You feel this as emotional volatility, intense reactions to small stressors, sensory overwhelm in crowded environments, or difficulty filtering background noise and activity. Adaptogens that increase dopamine or norepinephrine (like ginseng or rhodiola) can amplify this hyperreactivity. You need calming, stabilizing interventions instead.

Your BDNF gene encodes brain-derived neurotrophic factor, a protein that supports neuroplasticity, the brain’s ability to adapt to stress, learn from experience, and bounce back from adversity. BDNF is like the fertilizer that helps your brain rewire itself after stress. Without it, recovery is slower and less complete.

If you carry the Val66Met variant, your BDNF is secreted less efficiently in response to stress and learning. This means your brain has a reduced capacity to adapt to chronic stress and form new neural pathways that support coping. Roughly 30% of the population carries at least one Met allele. People with this variant show slower recovery from burnout, difficulty building stress-coping skills, and reduced response to therapy and meditation practices that rely on neuroplasticity.

You feel this as prolonged emotional recovery after stress, difficulty building new coping habits even with consistent practice, or feeling stuck in the same stress patterns despite effort to change them. Adaptogens alone won’t accelerate neuroplasticity if BDNF production is constrained. You need interventions that specifically upregulate BDNF expression.

Your NR3C1 gene encodes the glucocorticoid receptor, the protein that cortisol binds to in order to exert its effects on the body. When NR3C1 is functioning normally, cortisol can bind effectively and trigger the appropriate stress response. The system is responsive and proportional to the actual threat.

If you carry certain NR3C1 variants, your glucocorticoid receptor is less sensitive to cortisol signaling. This means even normal cortisol levels may fail to trigger the appropriate feedback loop, leaving your stress response dysregulated and your recovery impaired. Roughly 20-30% of the population carries variants that reduce receptor sensitivity, and this is often compounded in people with a history of early-life stress or ongoing adversity.

You feel this as difficulty responding to calming cues, a sense that relaxation techniques don’t work, or a nervous system that seems stuck in high alert. Even when objectively safe, you feel threatened. Adaptogens that modulate cortisol assume your cortisol receptors are working normally. If they’re not, standard adaptogens won’t be effective.